Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, parallel group, multicenter study of subjects with Stage 1 or 2
essential hypertension who are not at target blood pressure (<140/90mmHg) at Baseline.
Subjects will be randomized to receive either carvedilol CR + lisinopril or lisinopril +
placebo. Subjects will be uptitrated over a 6 week period until target blood pressure
(<140/90mmHg) is met. The primary objective of the study is to compare the proportion of
subjects who achieve target blood pressure after 6 weeks of treatment.